300685 艾德生物
按盤價 
20.640 +2.220 (+12.052%)
20.640 +2.220 (+12.052%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 4.140 | 18.530 | 14.372 | 16.327 | 18.416 |
| 總資產報酬率 ROA (%) | 3.590 | 16.374 | 12.744 | 14.584 | 16.636 |
| 投入資產回報率 ROIC (%) | 3.844 | 17.738 | 13.892 | 15.739 | 17.948 | 邊際利潤分析 |
| 銷售毛利率 (%) | 82.459 | 82.591 | 84.747 | 83.968 | 82.449 |
| 營業利潤率 (%) | 37.663 | 34.851 | 26.419 | 28.869 | 34.157 |
| 息稅前利潤/營業總收入 (%) | 39.675 | 32.486 | 23.677 | 25.779 | 30.404 |
| 淨利潤/營業總收入 (%) | 32.709 | 30.162 | 22.982 | 25.058 | 31.382 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 96.021 | 100.582 | 108.654 | 101.688 | 62.944 |
| 價值變動淨收益/利潤總額(%) | 1.564 | 3.560 | -0.168 | -0.678 | 0.691 |
| 營業外收支淨額/利潤總額(%) | -2.256 | -1.583 | -1.068 | -2.167 | -0.552 | 償債能力分析 |
| 流動比率 (X) | 15.142 | 11.526 | 9.180 | 9.288 | 13.974 |
| 速動比率 (X) | 14.812 | 11.316 | 9.003 | 9.123 | 13.617 |
| 資產負債率 (%) | 14.156 | 12.425 | 10.729 | 11.968 | 9.158 |
| 帶息債務/全部投入資本 (%) | 8.253 | 4.306 | 1.828 | 2.740 | 2.956 |
| 股東權益/帶息債務 (%) | 1,101.889 | 2,201.638 | 5,293.106 | 3,524.047 | 3,255.050 |
| 股東權益/負債合計 (%) | 606.408 | 704.842 | 832.035 | 735.583 | 991.900 |
| 利息保障倍數 (X) | 13.956 | -17.830 | -9.614 | -10.407 | -8.527 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 213.826 | 176.012 | 170.220 | 168.117 | 188.285 |
| 存貨周轉天數 (天) | 82.128 | 61.898 | 67.201 | 66.302 | 79.288 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 27/05/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
